Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway

Published:2024-05-23 Issue: Volume: Page:
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Kim Yeyoung,Lee Soyoung,Jin Meiling,Choi Young-Ae,Choi Jin Kyeong,Kwon Taeg Kyu,Khang Dongwoo,Kim Sang-Hyun

Funder

National Research Foundation of Korea

한국연구재단 , 대한민국

Ministry of Trade, Industry and Energy

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10753-024-02034-1.pdf

Reference48 articles.

1. Wang, J., Y. Zhou, H. Zhang, L. Hu, J. Liu, L. Wang, T. Wang, H. Zhang, L. Cong, and Q. Wang. 2023. Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduction and Targeted Therapy 8: 138.

2. Jarosz, M., S. Syed, M. Błachut, and K. Badura Brzoza. 2020. Emotional distress and quality of life in allergic diseases. Wiadomosci Lekarskie 73: 370–373.

3. Sibilano, R., B. Frossi, and C.E. Pucillo. 2014. Mast cell activation: A complex interplay of positive and negative signaling pathways. European Journal of Immunology 44: 2558–2566.

4. Li, Y., P.S. Leung, M.E. Gershwin, and J. Song. 2022. New mechanistic advances in FcεRI-mast cell–mediated allergic signaling. Clinical Reviews in Allergy and Immunology 63: 431–446.

5. Grunau, B.E., M.O. Wiens, B.H. Rowe, R. McKay, J. Li, T.W. Yi, R. Stenstrom, R.R. Schellenberg, E. Grafstein, and F.X. Scheuermeyer. 2015. Emergency department corticosteroid use for allergy or anaphylaxis is not associated with decreased relapses. Annals of Emergency Medicine 66: 381–389.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3